Veritas In Silico Inc. (130A) Press Release
Joint Patent Application Filed for lncRNA-Targeting Drugs
Earlier from Veritas In Silico
- Personnel Changes in Executive Officer
- TABLE-Veritas In Silico -2025 parent results
- TABLE-Veritas In Silico - 9-MTH parent results
- TABLE-Veritas In Silico -2025 parent forecast
